Our results in breast and thyroid cancer cells show that SIRT5 activation, Pi binding or SIRT5 activation plus Pi binding greatly reduces cancer cell growth by impinging on autophagy and mitophagy and increasing ROS production. The gene discussed is SIRT5; the disease is thyroid gland carcinoma.